Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO-MEDICO
🇮🇹
Italy
Country
🇮🇹
Italy
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.
Completed
Conditions
Pancreas Cancer
Subscribe
First Posted Date
2023-07-25
Last Posted Date
2023-07-25
Lead Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Target Recruit Count
2034
Registration Number
NCT05959213
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy